financetom
Business
financetom
/
Business
/
Nike CEO John Donahoe to retire
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Nike CEO John Donahoe to retire
Sep 20, 2024 2:46 AM

Sept 19 (Reuters) - Nike's ( NKE ) chief executive

officer John Donahoe will retire, and Elliott Hill will become

president and CEO effective Oct. 14, the company said on

Thursday.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Arbor Realty Trust Q4 Distributable Earnings, Net Interest Income Decrease
Arbor Realty Trust Q4 Distributable Earnings, Net Interest Income Decrease
Feb 21, 2025
08:53 AM EST, 02/21/2025 (MT Newswires) -- Arbor Realty Trust ( ABR ) reported Q4 distributable earnings Friday of $0.40 per diluted share, down from $0.51 a year earlier. Four analysts polled by FactSet expected $0.38. Net interest income for the quarter ended Dec. 31 was $82.9 million, down from $103.6 million a year earlier. Comparable analyst estimates were not...
JPMorgan analysts see no special Aramco dividend this year
JPMorgan analysts see no special Aramco dividend this year
Feb 21, 2025
DUBAI (Reuters) - Saudi Aramco is forecast to have no performance-linked dividend this year after a more balanced 2024 cash cycle following earlier bumper results that backed the special payout, JPMorgan ( JPM ) said in a research note on Friday. The past 18M (18 months) has delivered elevated performance-linked divs funded by premium FY22/23 financials and we remind this...
Telomir Pharmaceuticals Says Telomir-1 Compound Stabilizes Silver for Advanced Medical Applications
Telomir Pharmaceuticals Says Telomir-1 Compound Stabilizes Silver for Advanced Medical Applications
Feb 21, 2025
08:55 AM EST, 02/21/2025 (MT Newswires) -- Telomir Pharmaceuticals ( TELO ) said Friday it was able to stabilize both Silver(I) and the highly reactive Silver(II) in a biologically compatible form with its Telomir-1 compound. The company said the Telomir-1 compound would help overcome hurdles in silver-based medical applications and open up new possibilities for advanced antimicrobial treatments, wound care,...
What's Going On With Gene Therapy Company Bluebird Bio Stock Today?
What's Going On With Gene Therapy Company Bluebird Bio Stock Today?
Feb 21, 2025
Bluebird Bio, Inc. ( BLUE ) , on Friday, entered into a definitive agreement to be acquired by global investment firms Carlyle Group Inc. ( CG ) and SK Capital Partners. The agreement, which also includes a team of biotech executives, will see Bluebird Bio’s stockholders receive $3.00 per share in cash, along with a contingent value right, which could...
Copyright 2023-2026 - www.financetom.com All Rights Reserved